Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.
PURPOSE OF REVIEW Immunotherapy has transformed the treatment of many malignancies but has not yet produced comparable improvements in survival for patients with gliomas. This review examines the biological rationale for immunotherapy across molecularly defined gliomas, lessons from unsuccessful immune checkpoint inhib...